1990
DOI: 10.1159/000186026
|View full text |Cite
|
Sign up to set email alerts
|

Introduction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…In the RAS system, the first enzyme involved is the acid aspartate-protease renin [ 11 ], which converts angiotensinogen to angiotensin I (AngI). This angiotensin is inactive, and is converted to active angiotensin II (AngII) by the dipeptidilcarboxypeptidase angiotensin-converting enzyme (ACE-1) [ 12 ]. Through a similar mechanism of AngII metabolism are produced active angiotensin III (AngIII) and angiotensin IV (AngIV), with the involvement of angiotensinases of aminopeptidase-type.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the RAS system, the first enzyme involved is the acid aspartate-protease renin [ 11 ], which converts angiotensinogen to angiotensin I (AngI). This angiotensin is inactive, and is converted to active angiotensin II (AngII) by the dipeptidilcarboxypeptidase angiotensin-converting enzyme (ACE-1) [ 12 ]. Through a similar mechanism of AngII metabolism are produced active angiotensin III (AngIII) and angiotensin IV (AngIV), with the involvement of angiotensinases of aminopeptidase-type.…”
Section: Introductionmentioning
confidence: 99%
“…AngII and AngIII mediates their action through AT 1 and AT 2 receptor subtypes [ 14 , 15 ], whereas AngIV seems to act at the AT 4 receptor subtype [ 4 ], which has been identified as the enzyme insulin-regulated aminopeptidase (IRAP) or, more recently, as the hepatocyte growth factor (HGF)/c-Met receptor system [ 5 ]. On the other hand, tissue carboxypeptidases and other proteolytic enzymes (such as trypsin, chymotrypsin, pepsin and others) contribute to the inactivation of the active forms of angiotensins, transforming them into inactive fragments and amino acid constituents [ 4 , 12 ]. A separate pathway for the synthesis of AngIII, independent of AngII formation, is via the nonapeptide [des-Asp1]AngI, formed from AngI by ASAP [ 16 ].…”
Section: Introductionmentioning
confidence: 99%